The mark consists of the word "ENTADFI" with "ENT" in purple and "ADFI" in green, and above, a capsule design being purple on the left side with a light purple bar toward the center, and green on the right side with a light green bar toward the center.
Mark For: ENTADFI™ trademark registration is intended to cover the category of pharmaceutical product for treatment of symptoms of an enlarged prostate and for improving urinary flow. [all]
>The color(s) purple and green is/are claimed as a feature of the mark. The mark consists of the word "ENTADFI" with "ENT" in purple and "ADFI" in green, and above, a capsule design being purple on the left side with a light purple bar toward the center, and green on the right side with a light green bar toward the center.
Status
2022-10-31 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.
3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark Type
TRADEMARK
Standard Character Claim
No
Register
PRINCIPAL
Current Location
TMO LAW OFFICE 301 2022-10-01
Basis
1(b)
Class Status
ACTIVE
Primary US Classes
005:
Adhesives
006:
Chemicals and Chemical Compositions
018:
Medicines and Pharmaceutical Preparations
044:
Dental, Medical and Surgical Appliances
046:
Foods and Ingredients of Foods
051:
Cosmetics and Toilet Preparations
052:
Detergents and Soaps
Primary International Class
005 - Primary Class
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
Bruce S. Londa
Attorney Docket Number
119595-1
Timeline
2021-08-13
Application Filed
2021-08-17
Location: NEW APPLICATION PROCESSING
2021-08-17
Status: Live/Pending
2021-08-17
Transaction Date
2022-05-03
Published
2022-08-24
Date of First Use
2022-08-24
Date of Use In Commerce
2022-10-01
Location: TMO LAW OFFICE 301
2022-10-01
Status: A Statement of Use has been forwarded to the examining attorney for examination.
Capsules, medicinal/nonmedicinal; Pills; Tablets, medicines; Tablets, nonmedical products in tablet form
Attorney of Record
BRUCE S. LONDA NORRIS MCLAUGHLIN, P.A. 7 TIMES SQUARE 21ST FLOOR NEW YORK, NY 10036
Good, Services, and Codes
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical product for treatment of symptoms of an enlarged prostate and for improving urinary flow. FIRST USE: 20220824. FIRST USE IN COMMERCE: 20220824
International Codes:
5
U.S. Codes:
005,006,018,044,046,051,052
Type Code
Type
CC0000
The color(s) purple and green is/are claimed as a feature of the mark.
DM0000
The mark consists of the word "ENTADFI" with "ENT" in purple and "ADFI" in green, and above, a capsule design being purple on the left side with a light purple bar toward the center, and green on the right side with a light green bar toward the center.
Trademark Filing History
Description
Date
Proceeding Number
STATEMENT OF USE PROCESSING COMPLETE
2022-10-01
66530
CASE ASSIGNED TO INTENT TO USE PARALEGAL
2022-10-01
66530
USE AMENDMENT FILED
2022-09-20
66530
TEAS STATEMENT OF USE RECEIVED
2022-09-20
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2022-06-28
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.